Free Trial

BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts

BridgeBio Pharma logo
$37.13 +0.32 (+0.87%)
As of 12:50 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

BridgeBio Pharma Latest Earnings Summary

Upcoming Q1
Earnings Date
Apr. 30Before Market OpensEstimated
Actual EPS
(Feb. 20)
-$1.31 Missed By -$0.22
Consensus EPS
(Feb. 20)
-$1.09

BridgeBio Pharma posted Q4 2024 earnings on February 20, 2025, reporting an EPS of -$1.31, which missed the consensus estimate of -$1.09 by $0.22. Quarterly revenue was reported to be $5.88 million, above analysts' expectations of $4.04 million. With a trailing EPS of -$2.41, BridgeBio Pharma's earnings are expected to decrease next year, from ($2.56) to ($3.66) per share.

BBIO Upcoming Earnings

BridgeBio Pharma's next earnings date is estimated for Wednesday, April 30, 2025, based off prior year's reporting schedules.

Get BridgeBio Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BridgeBio Pharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BridgeBio Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.83-$0.83-$0.83
Q2 20251-$0.93-$0.93-$0.93
Q3 20251-$0.93-$0.93-$0.93
Q4 20251-$1.02-$1.02-$1.02
FY 20254($3.71)($3.71)($3.71)

BridgeBio Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/30/2025
(Estimated)
-------
2/20/2025Q4 2024-$1.09-$1.31 -$0.22-$1.40$4.04M$5.88M
8/1/2024Q2 2024-$1.00-$0.39+$0.61-$1.65$3.96M$2.17M
5/2/2024Q1 2024-$0.40-$0.05+$0.35$0.10$140.06M$211.12M
2/22/2024Q4 2023-$0.87-$0.96 -$0.09-$0.96$4.78M$1.74M
11/2/2023Q3 2023-$0.86-$1.08 -$0.22-$1.08$5.29M$4.09M
8/3/2023Q2 2023-$0.80-$0.98 -$0.18-$0.98$2.99M$1.60M
5/4/2023Q1 2023-$0.83-$0.92 -$0.09-$0.92$3.23M$1.83M
2/23/2023Q4 2022-$0.86-$0.87 -$0.01-$0.82$12.24M$1.87M

BridgeBio Pharma Earnings - Frequently Asked Questions

BridgeBio Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, April 30th, 2025 based off last year's report dates. Learn more on BBIO's earnings history.

In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) missed the analysts' consensus estimate of ($1.09) by $0.22 with a reported earnings per share (EPS) of ($1.31). Learn more on analysts' earnings estimate vs. BBIO's actual earnings.

BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $9.30 million.

BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$643.20 million. BBIO has generated -$2.41 earnings per share over the last four quarters.

BridgeBio Pharma's earnings are expected to decrease from ($2.56) per share to ($3.66) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:BBIO) was last updated on 2/21/2025 by MarketBeat.com Staff
From Our Partners